Printer Friendly

Browse Lymphomas topic

Drug therapy subtopic

Articles

1-172 out of 172 article(s)
Title Author Type Date Words
LAS VEGAS SANDS / ADELSON TAKES LEAVE FOR CANCER TREATMENT. Jan 8, 2021 211
AstraZeneca receives EU approval for leukaemia treatment. Nov 10, 2020 314
Epizyme's Tazverik Phase 2 data featured in two Lancet Oncology publications. Oct 7, 2020 235
Approval for drugs to fight 4 cancers. VIVIENNE AITKEN Health Editor Sep 8, 2020 170
Treatment of childhood Hodgkin lymphoma in sub-Saharan Africa: A report from the French-African Paediatric Oncology Group (GFAOP). Traore, F.; Akonde, F.B. Diagne; Togo, B.; Moreira, C.; Rakotomahefa, N.M.; Pondy, A.; Bouda, C.; Ha Clinical report Sep 1, 2020 4834
Nawton schoolgirl Grace highlights plight of cancer research funding due to Covid-19; A Nawton schoolgirl, who is celebrating one year since completing treatment for cancer, is calling on people to help tackle the devastating loss of funding for cancer research. Aug 5, 2020 515
MorphoSys And Incyte Celebrate US Green Light For Blood Cancer Drug. Aug 3, 2020 151
Roche In US Breakthrough Status For Cancer Drug; Teams With Blueprint. Jul 14, 2020 374
Oncternal Therapeutics announces orphan drug designations of cirmtuzumab by FDA. Jun 30, 2020 178
FDA approves Takeda's Alunbrig as first-line treatment for rare lung cancer. May 22, 2020 191
Delayed Chylothorax during Treatment of Follicular Lymphoma with a Malignant Pleural Effusion. Ekeke, Chigozirim N.; Chan, Ernest G.; Luketich, James D.; Dhupar, Rajeev Mar 31, 2020 1556
Probe into treatment of cancer patient. Disease/Disorder overview Mar 14, 2020 269
FDA Accepts of New Drug Application for Filing with Priority Review for Tazverik for the Treatment of Follicular Lymphoma. Feb 18, 2020 528
Girl, 13, battling with cancer says rescue dog 'saved' her at lowest point; Gracie Pope was 'given strength' by a stray dog rescued by her family when she was diagnosed with stage four Hodgkin's lymphoma and underwent gruelling treatment. By, Kelly Jenkins Jan 11, 2020 391
Epizyme submits tazemetostat NDA to FDA for treatment of follicular lymphoma. Dec 19, 2019 264
Epizyme submits tazemetostat NDA to FDA for treatment of follicular lymphoma. Dec 19, 2019 268
Clinical Spectrum and Treatment Outcomes of HIV Associated Cancers in a Tertiary Care Centre. Elumalai, Senthilkumar; Kannan, Kalaichelvi; Sundarrajan, Sureshkumar; Gopal, Raja Report Dec 16, 2019 2551
AstraZeneca gains US FDA approval for lymphocytic cancer drug Calquence. Nov 25, 2019 216
AstraZeneca gains US FDA approval for lymphocytic cancer drug Calquence. Nov 25, 2019 212
Verastem Oncology submits Marketing Authorization Application to European Medicines Agency for COPIKTRA for cancer patients. Nov 25, 2019 237
Verastem Oncology submits Marketing Authorization Application to European Medicines Agency for COPIKTRA for cancer patients. Nov 25, 2019 233
Calquence Approved to Treat CLL, SLL; Progression free-survival longer with Calquence versus other standard treatments. Nov 22, 2019 295
FDA approves Brukinsa therapy to treat patients with relapsed and refractory mantle cell lymphoma. Nov 15, 2019 230
FDA approves Brukinsa therapy to treat patients with relapsed and refractory mantle cell lymphoma. Nov 15, 2019 226
Viracta receives FDA's FTD for nanatinostat -valganciclovir combination for treating EBV-associated lymphomas. Nov 13, 2019 218
Viracta receives FDA's FTD for nanatinostat -valganciclovir combination for treating EBV-associated lymphomas. Nov 13, 2019 214
US FDA supplemental New Drug Application submitted for AbbVie's IMBRUVICA in combination with rituximab. Nov 12, 2019 221
US FDA supplemental New Drug Application submitted for AbbVie's IMBRUVICA in combination with rituximab. Nov 12, 2019 217
Abbvie (NYSE: ABBV) - AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA[R] (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia -- 8/11/2019. Nov 11, 2019 359
Sareum Holdings to showcase potential of new cancer drug at leading industry conference. Conference news Sep 28, 2019 235
Pfizer UK - FDA Approves Pfizer's Biosimilar, Ruxience[TM] (Rituximab-Pvvr), For Certain Cancers And Autoimmune Conditions -- 23/7/2019. Aug 14, 2019 373
Pfizer UK - FDA Approves Pfizer's Biosimilar, Ruxience[TM] (Rituximab-Pvvr), For Certain Cancers And Autoimmune Conditions - 23/7/2019. Aug 6, 2019 372
Pfizer UK - FDAApproves Pfizer's Biosimilar, Ruxience[TM] (Rituximab-Pvvr), For Certain Cancers And Autoimmune Conditions -- 23/7/2019. Aug 1, 2019 360
FDA Approves Pfizer's Biosimilar, Ruxience (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions. Jul 25, 2019 267
Doctors 'made anxiety error' in cancer patient's treatment; medics mistook side effects, inquest hears. Jul 23, 2019 642
Treatment of leukemia, lymphoma and other blood cancers among Filipinos now offers real hope for cure. Jun 21, 2019 1510
FDA Grants Genentech's Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma. Jun 12, 2019 950
Roche Gets Accelerated Approval In US For Lymphoma Drug Polivy. Jun 11, 2019 333
FDA grants Genentech's Polivy accelerated approval in aggressive lymphoma. Jun 10, 2019 187
FDA Approves Revlimid In Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma. May 30, 2019 242
Celgene Corporation (NASDAQ: CELG) - FDA Approves REV LI MID[R] (Lenalidomide) In Combination With Rituximab For the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma -- 28/5/2019. May 29, 2019 622
Celgene announces FDA approval of Revlimid/rituximab combo. May 28, 2019 139
Genentech (SIX: RO, ROG; OTCQX: RHHBY) - Genentech Announces FDA Approval for Venclexta plus Gazyva for People With Previously Untreated Chronic Lymphocytic Leukemia -- 15/5/2019. May 20, 2019 538
First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research Institute. Mar 21, 2019 631
European Medicines Agency's committee recommends Pfizer's lung cancer drug. Mar 5, 2019 188
European Medicines Agency's committee recommends Pfizer's lung cancer drug. Mar 5, 2019 184
UAE expat freezes her eggs before cancer treatment. Feb 26, 2019 647
Celltrion and Teva Announce FDA Approval of Truxima, a Biosimilar to Rituxan, for Three Non-Hodgkin's Lymphoma Indications. Dec 6, 2018 360
Nordic Nanovector selects first US clinical trial site for Betalutin Lymphoma drug. Oct 29, 2018 260
Nordic Nanovector selects first US clinical trial site for Betalutin Lymphoma drug. Oct 29, 2018 256
Daiichi Sankyo's axicabtagene ciloleucel granted Orphan Drug designation by Japanese Ministry. Oct 4, 2018 205
Daiichi Sankyo's axicabtagene ciloleucel granted Orphan Drug designation by Japanese Ministry. Oct 4, 2018 201
Cancer treatment contributed to death of Lewis, 20. Sep 5, 2018 513
Chinese regulator accepts BeiGene's NDA for Hodgkin's lymphoma treatment. Aug 31, 2018 243
Chinese regulator accepts BeiGene's NDA for Hodgkin's lymphoma treatment. Aug 31, 2018 239
China National Drug Administration grants marketing authorisation to Roche's Alecensa. Aug 22, 2018 175
China National Drug Administration grants marketing authorisation to Roche's Alecensa. Aug 22, 2018 171
Gaza without Cancer Medicine as Haley Blames Arabs for Washington's Sins. Aug 22, 2018 1417
How mum put life-saving cancer treatment on hold so she could have children. Aug 16, 2018 922
Mum: I put my treatment for cancer on hold to have children. Aug 16, 2018 1002
Celgene Study of Revlimid/Rituximab Combination for Treatment of Relapsed/Refractory Indolent Lymphoma Demonstrates Improvement in PFS. Clinical report Jul 26, 2018 228
Baylor University Medical Center and Texas Oncology begin breakthrough CAR-T cancer treatment for patients with non-Hodgkin's lymphoma. Brief article Jul 1, 2018 241
US FDA Grants Fast Track Designation to Nordic Nanovector for Betalutin for Follicular Lymphoma. Jun 15, 2018 295
Nordic Nanovector's Betalutin granted Fast Track Designation by US FDA for follicular lymphoma. Jun 12, 2018 407
Nordic Nanovector's Betalutin granted Fast Track Designation by US FDA for follicular lymphoma. Jun 12, 2018 403
AbbVie wins US FDA approval for VENCLEXTA in combination with rituximab for treating chronic lymphocytic leukemia. Jun 11, 2018 275
AbbVie wins US FDA approval for VENCLEXTA in combination with rituximab for treating chronic lymphocytic leukemia. Jun 11, 2018 271
Pfizer's Xalkori receives FDA breakthrough therapy designation in 2 indications. May 29, 2018 152
Sutro Doses First Patients in Clinical Trial of STRO-001 for Treatment of Lymphoma and Multiple Myeloma. Apr 30, 2018 302
Save Sebastian; Parents desperate appeal to fund three-year-old's cancer treatment. Apr 28, 2018 433
Sutro Doses First Patients in Clinical Trial of STRO-001 for Treatment of Lymphoma and Multiple Myeloma. Apr 27, 2018 302
FDA Approves Seattle Genetics' Adcetris in Combination with Chemotherapy for Adults with Certain Hodgkin Lymphomas. Mar 23, 2018 349
I still have reduced fertility after cancer treatment so we're just grateful that we have Sam.. 2fm DJ Louise on fears she can't have another baby after battling disease. Mar 16, 2018 546
How a son of widow get treatment for lymphoma. Feb 17, 2018 259
Young Hodgkin's Lymphoma Rower Grows from Treatment Experience. Feb 2, 2018 896
Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment. Teow, Sin-Yeang; Yap, Hooi-Yeen; Peh, Suat-Cheng Jan 1, 2018 6723
Efficacy of Carfilzomib, Lenalidomide, and Dexamethasone for Extramedullary Intracranial Localization of Multiple Myeloma. Mele, Giuseppe; Pastore, Domenico Jan 1, 2018 1671
Seattle Genetics Files sBLA to FDA for Adcetris for Treatment of Hodgkin Lymphoma. Nov 3, 2017 310
FDA Approves Genentech's Rituxan Hycela for Subcutaneous Injection in Certain Blood Cancers. Jun 23, 2017 730
To ensure availability of Rituximab and Trastuzumab at affordable prices. May 31, 2017 542
Novartis wins US FDA approval to expand use of Zykadia for treating patients with metastatic non-small cell lung cancer. May 29, 2017 278
Novartis wins US FDA approval to expand use of Zykadia for treating patients with metastatic non-small cell lung cancer. May 29, 2017 274
US FDA Grants Breakthrough Therapy Designation to Pfizer's Lorlatinib Next-Generation ALK/ROS1 Inhibitor for ALK-Positive Metastatic Non-Small Cell Lung Cancer. Apr 27, 2017 355
Animal drug approved for canine lymphoma. Apr 1, 2017 155
FDA Advisory Committee Unanimously Recommends Approval of Genentech's Subcutaneous Rituximab for Certain Blood Cancers. Mar 30, 2017 466
Merck's KEYTRUDA gains European Medicines Agency approval for treatment of Relapsed or Refractory Classical Hodgkin Lymphoma. Mar 27, 2017 200
Merck's KEYTRUDA gains European Medicines Agency approval for treatment of Relapsed or Refractory Classical Hodgkin Lymphoma. Mar 27, 2017 196
FDA Approves US Merck's Keytruda for Adult and Pediatric Patients with Classical Hodgkin Lymphoma. Mar 15, 2017 711
Rituximab maintenance strategy in advanced follicular lymphoma: Facts and controversies. Milunovic, Vibor; Patekar, Martina Bogeljic; Jakubac, Karla Misura; Rogulj, Inga Mandac; Radic-Krist Report Mar 1, 2017 9214
Roche gets EU approval for lung cancer drug Alecensa. Feb 22, 2017 263
Roche gets EU approval for lung cancer drug Alecensa. Feb 22, 2017 259
US FDA Approves Imbruvica for Marginal Zone Lymphoma Patients. Jan 23, 2017 314
US FDA Approves Imbruvica as First Treatment for Rare Type of Non-Hodgkin's Lymphoma. Jan 23, 2017 543
AbbVie's IMBRUVICA for the treatment of relapsed/refractory (R/R) marginal zone lymphoma wins US FDA approval. Jan 20, 2017 296
AbbVie's IMBRUVICA for the treatment of relapsed/refractory (R/R) marginal zone lymphoma wins US FDA approval. Jan 20, 2017 292
Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review. Mannina, Donato; Loteta, Barbara Clinical report Jan 1, 2017 2283
Novartis Drug Zykadia Beats Chemotherapy In Lung Cancer Patients. Dec 7, 2016 400
Bristol-Myers Squibb receives European Commission approval for Opdivo Hodgkin lymphoma drug. Nov 24, 2016 206
Bristol-Myers Squibb receives European Commission approval for Opdivo Hodgkin lymphoma drug. Nov 24, 2016 202
Patients to miss out on cancer drugs. Aug 10, 2016 193
Celgene receives European Commission approval for Revlimid lymphoma treatment. Jul 19, 2016 187
Celgene receives European Commission approval for Revlimid lymphoma treatment. Jul 19, 2016 183
Anti-cancer compounds target leukemia, lymphoma blood cancers: a new class of drugs drives cancer cells to suicide. Jun 1, 2016 521
'Help us give our Kevin one last chance' FAMILY IN PLEA FOR PS30k TO SEND BUILDER, 26, FOR CONTROVERSIAL CANCER TREATMENT. May 10, 2016 302
Genentech, a member of the Roche Group, received approval from the FDA for Gazyva (obinutuzumab) plus bendamustine chemotherapy followed by Gazyva alone as a new treatment for people with follicular lymphoma who did not respond to a Rituxan (rituximab) regimen. May 1, 2016 303
ProNAi Therapeutics' oncology drug candidate PNT2258 has been granted Orphan Drug Designation by the FDA for the treatment of diffuse large B-cell lymphoma (DLBCL). May 1, 2016 212
Seattle Genetics commences phase one clinical trial of B-cell non-Hodgkin lymphoma treatment. Feb 29, 2016 156
AbbVie passes EMA's orphan drug designation for venetoclax for the treatment of acute myeloid leukemia (AML). Feb 29, 2016 338
Seattle Genetics commences phase one clinical trial of B-cell non-Hodgkin lymphoma treatment. Feb 29, 2016 152
AbbVie passes EMA's orphan drug designation for venetoclax for the treatment of acute myeloid leukemia (AML). Feb 29, 2016 334
New class of drug raises hope for blood cancer patients. Feb 18, 2016 161
Research Leads to New Treatment for Lymphoma in Dogs and Cats. Jan 13, 2016 285
Revolutionary drug that has given cancer victim mum hope. Dec 26, 2015 708
Takeda launches new treatment for Hodgkin's lymphoma in Philippines. Oct 17, 2015 251
US FDA approves Bristol-Myers Squibb's Opdivo injection for lung cancer. Oct 13, 2015 157
US FDA approves Bristol-Myers Squibb's Opdivo injection for lung cancer. Oct 13, 2015 153
Promising treatments for lymphoma: antibody therapy, still under evaluation, has been used successfully in people with cancer of the white blood cells. Oct 1, 2015 901
Charity's fears as more cancer patients endure treatment wait. Sep 30, 2015 144
MRC Technology collaborates with University of Lausanne for lymphoma treatment. Sep 28, 2015 127
MRC Technology collaborates with University of Lausanne for lymphoma treatment. Sep 28, 2015 123
Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas. Zhou, Ping; Liu, Peng; Zhou, Sheng-Yu; He, Xiao-Hui; Han, Xiao-Hong; Qin, Yan; Yang, Sheng; Zhang, C Report Sep 20, 2015 4408
CASI Pharmaceuticals unveils anti-cancer drug ZEVALIN in Hong Kong hospitals. Jul 21, 2015 224
CASI Pharmaceuticals unveils anti-cancer drug ZEVALIN in Hong Kong hospitals. Jul 21, 2015 220
Hodgkin lymphoma treatment recommended. Jul 9, 2015 165
Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy: A Systematic Review and Meta-Analysis. Ren, Yuan-Rong; Jin, Yong-Dong; Zhang, Zhi-Hui; Li, Li; Wu, Ping Report Mar 1, 2015 3591
NADIA MUM HOPES TRIAL DRUG WILL EXTEND LIFE; Model tells how new medicine is helping Berenice fight cancer. Dec 29, 2014 531
Bone marrow metastasis of prostatic adenocarcinoma with post-treatment foamy-like changes: a diagnostic pitfall. Yigit, Nuri; Geyer, Julia Turbiner Case study Dec 1, 2014 1854
Wonder drug killed off my 70 tumours in 2 weeks; PATIENT TELLS OF HIS JOY Ian had weeks to live when armour-piercing cancer treatment put him into remission. Feb 26, 2014 454
Companion biomarkers: paving the pathway to personalized treatment for cancer. Duffy, Michael J.; Crown, John Report Oct 1, 2013 8274
Cancer monoclonal antibody market to be worth USD 34bn by 2017. Sep 4, 2013 175
Celgene Corporation gets US FDA's approval for REVLIMID for treating relapsed or refractory mantle cell lymphoma. Jun 6, 2013 251
Research: cancer treatment may increase heart risks: Cleveland Clinic study finds that cancer survivors who had chest radiation therapy may face higher risks after having major heart surgery. Jun 1, 2013 482
Leukaemia sufferers' drug hope. May 16, 2013 239
Sheffield Varsity scientists pave way for pioneering new cancer treatments. Feb 21, 2013 351
E. coli-derived L-asparaginase retains enzymatic and cytotoxic activity in vitro for canine and feline lymphoma after cold storage. Wypij, Jackie M.; Pondenis, Holly C. Report Jan 1, 2013 3607
Investigational targeted drug induces responses in aggressive lymphomas. Apr 2, 2012 144
Findings to help cancer treatment; University experts in breakthrough. Jan 5, 2012 552
Immunomedics unveils novel antibody-based drugs for lymphoma. Dec 13, 2011 186
Biovest's BiovaxID gets FDA Orphan Drug status for Waldenstrom's macroglobulinemia. Oct 28, 2011 157
Two cases of durable regression of primary B-cell cutaneous lymphoma following mistletoe treatment alone. Orange, M.; Lace, A.; Fonseca, M.; Laue, H.B. von; Geider, S. Report Oct 15, 2011 388
Helicobacter pylori infection: a review of current scientific research on the efficacy or potential of herbal medicine for the treatment of H. pylori infection of the gastric mucosa. Williams, Lee Report Sep 22, 2011 5465
Seattle Genetics gets FDA ok to treat two types of lymphoma after first medical treatments failed. Sep 1, 2011 174
Adcetris gets FDA approval for treatment of two types of lymphoma. Aug 22, 2011 283
Does raver's drug have role to play in treating cancer? MODIFIED VERSION OF ECSTASY CAN HELP TO DESTROY DANGEROUS CELLS. Aug 19, 2011 579
Targeted drug therapy found highly effective in lung cancer treatment. Jun 4, 2011 251
Drug combo therapy to effectively fight against blood cancer on the anvil. Jun 4, 2011 201
Drug trial scheme gives hope to cancer patients. May 18, 2011 361
Serum levels of interleukins 6, 10, and 13 before and after treatment of classic Hodgkin lymphoma. Gaiolla, Rafael D.; Domingues, Maria A.C.; Niero-Melo, Ligia; de Oliveira, Deilson Elgui Disease/Disorder overview Apr 1, 2011 6101
Genentech and Biogen Idec receives FDA approval for Rituxan for first-line maintenance use in follicular lymphoma. Jan 31, 2011 229
Camcer drugs cash; Life-extending treatments approved foruse in region. Jan 28, 2011 510
Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells. Wang, Hui; Ye, Yan; Pan, Si-Yuan; Zhu, Guo-Yuan; Li, Ying-Wei; Fong, David W.F.; Yu, Zhi-Ling Report Jan 15, 2011 5971
New drug shows promise against certain lung cancers. Oct 29, 2010 293
'Smart' lung cancer drug shows promise. Oct 28, 2010 513
New oral drug promises treatment for aggressive lymphoma. Clinical report May 27, 2010 298
New drug type developed to kill lymphoma cells. May 12, 2010 375
Boffins design new class of drug that kills lymphoma cells. Apr 15, 2010 417
Novel treatment gives hope to lymphoma, leukemia patients. Feb 27, 2010 391
Biovest earns FDA Orphan Drug status for personalised lymphoma vaccine. Jan 8, 2010 140
Treatment of nonepitheliotropic cutaneous b-cell lymphoma in an umbrella cockatoo (Cacatua alba). Rivera, Samuel; McClearen, James R.; Reavill, Drury R. Report Dec 1, 2009 4587
Targeted immunotherapy may help treat lymphoma. Nov 1, 2009 318
Therapy-related hematological disorders following conventional chemotherapy for lymphoid malignancies in children. Spasova, Mariya Ivanova; Stoyanova, Angelina Asenova; Moumdjiev, Ivan Nikolov Report Jul 1, 2009 2886
A treatment designed to harness the body's immune system to fight cancer appeared to thwart two forms of the malignancy in studies, boosting prospects for weapons against the disease that act like vaccines. Brief article Jun 8, 2009 293
Infections emerge long after cancer's treatment. Jancin, Bruce Jun 1, 2009 250
I feel cheated at treatment refusal; FORMER NURSE DENIED DRUGS WHICH COULD HELP BEAT CANCER. Jan 27, 2009 662
Hopes lift on cancer drug trial. Aug 16, 2008 265
FDA launches safety review of TNF blockers: under investigation are the risks for lymphoma and other cancers from Enbrel, Humira, and Remicade. Mechcatie, Elizabeth Jul 15, 2008 846
MGH study finds effective treatment for brain tumor. Brief article Apr 1, 2008 114
Billy overjoyed at wonder drug; Cancer treatment ahead of official go-ahead. Mar 1, 2008 449
Intensified chemo works for AIDS-related lymphoma; beats CHOP regimen. Moon, Mary Ann Brief Article Oct 1, 2003 251
IL-12 may shrink cutaneous T-cell lymphomas in some. (Promising Early Results). Mahoney, Diana Feb 1, 2003 409
Immunomedics obtains patent for therapy of B-cell malignancies using antibodies. Brief Article Jun 1, 2001 397
Drug aids destruction of lymphoma cells. Seppa, N. Brief Article Dec 9, 2000 387

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters